Literature DB >> 25059532

Guanfacine modulates the emotional biasing of amygdala-prefrontal connectivity for cognitive control.

Kurt P Schulz1, Suzanne M Clerkin2, Jeffrey H Newcorn1, Jeffrey M Halperin3, Jin Fan3.   

Abstract

Functional interactions between amygdala and prefrontal cortex provide a cortical entry point for emotional cues to bias cognitive control. Stimulation of α2 adrenoceptors enhances the prefrontal control functions and blocks the amygdala-dependent encoding of emotional cues. However, the impact of this stimulation on amygdala-prefrontal interactions and the emotional biasing of cognitive control have not been established. We tested the effect of the α2 adrenoceptor agonist guanfacine on psychophysiological interactions of amygdala with prefrontal cortex for the emotional biasing of response execution and inhibition. Fifteen healthy adults were scanned twice with event-related functional magnetic resonance imaging while performing an emotional go/no-go task following administration of oral guanfacine (1mg) and placebo in a double-blind, counterbalanced design. Happy, sad, and neutral faces served as trial cues. Guanfacine moderated the effect of face emotion on the task-related functional connectivity of left and right amygdala with left inferior frontal gyrus compared to placebo, by selectively reversing the functional co-activation of the two regions for response execution cued by sad faces. This shift from positively to negatively correlated activation for guanfacine was associated with selective improvements in the relatively low accuracy of responses to sad faces seen for placebo. These results demonstrate the importance of functional interactions between amygdala and inferior frontal gyrus to both bottom-up biasing of cognitive control and top-down control of emotional processing, as well as for the α2 adrenoceptor-mediated modulation of these processes. These mechanisms offer a possibile method to address the emotional reactivity that is common to several psychiatric disorders.
Copyright © 2014 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Amygdala; Emotion; Go/no-go; Guanfacine; Prefrontal cortex; fMRI

Mesh:

Substances:

Year:  2014        PMID: 25059532      PMCID: PMC4146697          DOI: 10.1016/j.euroneuro.2014.06.016

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  49 in total

1.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.

Authors:  Joseph A Maldjian; Paul J Laurienti; Robert A Kraft; Jonathan H Burdette
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

2.  Nonstationary cluster-size inference with random field and permutation methods.

Authors:  Satoru Hayasaka; K Luan Phan; Israel Liberzon; Keith J Worsley; Thomas E Nichols
Journal:  Neuroimage       Date:  2004-06       Impact factor: 6.556

3.  Enhanced visuomotor associative learning following stimulation of alpha 2A-adrenoceptors in the ventral prefrontal cortex in monkeys.

Authors:  Min Wang; Zong-Xiang Tang; Bao-Ming Li
Journal:  Brain Res       Date:  2004-10-22       Impact factor: 3.252

4.  The relation between disinhibition and emotion regulation in boys with attention deficit hyperactivity disorder.

Authors:  Christy Mangione Walcott; Steven Landau
Journal:  J Clin Child Adolesc Psychol       Date:  2004-12

5.  Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD.

Authors:  F DeBock; J Kurz; S C Azad; C G Parsons; G Hapfelmeier; W Zieglgänsberger; G Rammes
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

6.  Topographic organization of projections from the amygdala to the visual cortex in the macaque monkey.

Authors:  D G Amaral; H Behniea; J L Kelly
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Differential expression of alpha2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects.

Authors:  John E Piletz; Gregory A Ordway; Grazyna Rajkowska; He Zhu; Violeta Klimek; Sharonda Swilley; Betty J Duncan; Warren May; Angelos E Halaris
Journal:  J Psychiatr Res       Date:  2003 Sep-Oct       Impact factor: 4.791

8.  The effect of mianserin on alpha-2 adrenergic receptor function in depressed patients.

Authors:  D S Charney; G R Heninger; D E Sternberg
Journal:  Br J Psychiatry       Date:  1984-04       Impact factor: 9.319

9.  A sensory signature that distinguishes true from false memories.

Authors:  Scott D Slotnick; Daniel L Schacter
Journal:  Nat Neurosci       Date:  2004-05-23       Impact factor: 24.884

10.  Activation of alpha2 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala.

Authors:  M Frances Davies; Janet Tsui; Judy A Flannery; Xiangqi Li; Timothy M DeLorey; Brian B Hoffman
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

View more
  3 in total

Review 1.  Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.

Authors:  Ann C Childress; Floyd R Sallee
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.

Authors:  Michael Huss; Wai Chen; Andrea G Ludolph
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

3.  Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model.

Authors:  J L Lukkes; H P Drozd; S D Fitz; A I Molosh; D W Clapp; A Shekhar
Journal:  J Neurodev Disord       Date:  2020-01-15       Impact factor: 4.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.